Healthcare Sector Stocks
The Healthcare sector has a total of 1057 stocks, with a combined market cap of $9.24 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 46.40.
Market Cap
9.24T
Revenue
4.59T
Profits
199.08B
PE Ratio
46.40
Profit Margin
4.34%
Dividend Yield
0.38%
1058 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.10T | 2.96% | 2,933,771 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 643.30B | 3.05% | 9,089,652 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 449.91B | -0.04% | 8,238,268 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 388.86B | 2.44% | 5,800,451 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 318.26B | 1.64% | 10,174,350 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 298.04B | 1.56% | 2,130,028 | 60.44B |
| 7 | NVS | Novartis AG | 287.81B | 0.99% | 1,445,024 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 221.58B | 0.77% | 12,222,736 | 50.57B |
| 9 | AMGN | Amgen Inc. | 198.67B | 0.45% | 1,983,667 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 191.99B | -0.19% | 1,366,577 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 169.30B | 5.21% | 9,177,296 | 29.74B |
| 12 | ABT | Abbott Laboratories | 166.94B | 0.22% | 10,262,177 | 45.13B |
| 13 | ISRG | Intuitive Surgical, Inc. | 151.33B | -1.28% | 2,492,149 | 10.58B |
| 14 | DHR | Danaher Corporation | 137.44B | 0.29% | 3,248,899 | 24.78B |
| 15 | PFE | Pfizer Inc. | 137.19B | 1.48% | 44,101,385 | 63.32B |
| 16 | CVS | CVS Health Corporation | 133.12B | 2.20% | 4,967,278 | 405.62B |
| 17 | VRTX | Vertex Pharmaceuticals Incorporated | 132.55B | -1.39% | 2,292,907 | 12.22B |
| 18 | SYK | Stryker Corporation | 126.41B | 1.54% | 2,573,174 | 25.27B |
| 19 | BMY | Bristol-Myers Squibb Company | 118.38B | 2.24% | 10,048,426 | 48.48B |
| 20 | MDT | Medtronic plc | 107.31B | 0.93% | 9,080,715 | 36.36B |
| 21 | GSK | GSK plc | 106.77B | 0.43% | 3,673,256 | 43.29B |
| 22 | SNY | Sanofi | 103.93B | 0.87% | 2,667,184 | 54.60B |
| 23 | MCK | McKesson Corporation | 94.52B | 2.95% | 1,109,898 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 93.86B | 1.45% | 1,466,496 | 76.39B |
| 25 | ELV | Elevance Health, Inc. | 90.96B | 2.62% | 1,225,003 | 200.42B |
| 26 | CI | The Cigna Group | 75.82B | 1.65% | 1,095,730 | 277.89B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 68.80B | 4.07% | 918,937 | 14.92B |
| 28 | BSX | Boston Scientific Corporation | 67.33B | 1.57% | 13,000,733 | 20.61B |
| 29 | COR | Cencora, Inc. | 59.24B | 1.99% | 1,888,514 | 328.68B |
| 30 | ARGX | argenx SE | 57.72B | 0.34% | 385,325 | 4.74B |
| 31 | MDLN | Medline Inc. | 56.50B | 0.61% | 5,731,484 | 29.14B |
| 32 | CAH | Cardinal Health, Inc. | 56.14B | 0.92% | 3,236,464 | 250.74B |
| 33 | EW | Edwards Lifesciences Corporation | 54.60B | -0.38% | 4,445,101 | 6.30B |
| 34 | TAK | Takeda Pharmaceutical Company Limited | 53.19B | 0.41% | 2,654,300 | 28.34B |
| 35 | HUM | Humana Inc. | 47.38B | 0.45% | 831,101 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 44.98B | 0.93% | 610,399 | 4.45B |
| 37 | HLN | Haleon plc | 43.09B | 1.23% | 6,379,045 | 14.85B |
| 38 | BDX | Becton, Dickinson and Company | 43.07B | 0.49% | 1,757,628 | 22.23B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 42.94B | 2.73% | 980,503 | 4.29B |
| 40 | RVMD | Revolution Medicines, Inc. | 40.49B | 0.25% | 1,893,546 | - |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 40.35B | -1.81% | 5,566,054 | 17.35B |
| 42 | NTRA | Natera, Inc. | 40.28B | -0.89% | 1,759,682 | 2.50B |
| 43 | A | Agilent Technologies, Inc. | 37.04B | 0.41% | 2,456,409 | 7.23B |
| 44 | WAT | Waters Corporation | 36.81B | -1.05% | 806,668 | 3.77B |
| 45 | IQV | IQVIA Holdings Inc. | 34.75B | 1.10% | 1,345,886 | 16.63B |
| 46 | ONC | BeOne Medicines AG | 34.35B | -0.16% | 311,109 | 5.74B |
| 47 | RPRX | Royalty Pharma plc | 33.28B | 1.55% | 2,611,210 | 2.44B |
| 48 | ALC | Alcon Inc. | 32.80B | -2.14% | 3,476,024 | 10.63B |
| 49 | CNC | Centene Corporation | 32.65B | 0.11% | 4,169,953 | 178.33B |
| 50 | ZTS | Zoetis Inc. | 31.98B | 1.15% | 4,683,666 | 9.53B |
| 51 | RMD | ResMed Inc. | 31.70B | 0.62% | 1,726,352 | 5.54B |
| 52 | MRNA | Moderna, Inc. | 31.65B | -2.48% | 8,688,340 | 2.23B |
| 53 | VEEV | Veeva Systems Inc. | 31.24B | 0.15% | 2,392,126 | 3.32B |
| 54 | BIIB | Biogen Inc. | 30.37B | -1.32% | 1,156,880 | 9.94B |
| 55 | GEHC | GE HealthCare Technologies Inc. | 29.52B | 0.08% | 3,624,167 | 20.98B |
| 56 | ILMN | Illumina, Inc. | 29.01B | -1.32% | 2,582,918 | 4.39B |
| 57 | DXCM | DexCom, Inc. | 28.39B | 1.64% | 5,569,382 | 4.82B |
| 58 | PHG | Koninklijke Philips N.V. | 26.83B | 0.25% | 839,904 | 20.34B |
| 59 | MTD | Mettler-Toledo International Inc. | 26.18B | - | 175,476 | 4.09B |
| 60 | ROIV | Roivant Sciences Ltd. | 26.12B | 2.60% | 6,066,057 | 8.26M |
| 61 | WST | West Pharmaceutical Services, Inc. | 25.16B | -0.44% | 758,960 | 3.22B |
| 62 | INSM | Insmed Incorporated | 24.46B | 1.17% | 1,674,722 | 819.56M |
| 63 | UTHR | United Therapeutics Corporation | 23.93B | 3.01% | 513,745 | 3.17B |
| 64 | BNTX | BioNTech SE | 23.84B | 0.38% | 896,013 | 3.23B |
| 65 | INCY | Incyte Corporation | 23.58B | 2.10% | 1,667,760 | 5.36B |
| 66 | DGX | Quest Diagnostics Incorporated | 23.51B | -0.50% | 981,082 | 11.28B |
| 67 | LH | Labcorp Holdings Inc. | 23.28B | -0.19% | 615,791 | 14.14B |
| 68 | GH | Guardant Health, Inc. | 21.60B | -3.49% | 2,477,363 | 1.08B |
| 69 | STE | STERIS plc | 20.99B | 0.99% | 567,099 | 5.94B |
| 70 | VTRS | Viatris Inc. | 19.75B | 0.95% | 9,803,416 | 14.56B |
| 71 | THC | Tenet Healthcare Corporation | 17.99B | 1.28% | 792,451 | 21.46B |
| 72 | NBIX | Neurocrine Biosciences, Inc. | 17.85B | 1.95% | 1,033,826 | 3.10B |
| 73 | GMAB | Genmab A/S | 17.80B | 4.18% | 1,533,887 | 3.90B |
| 74 | ZBH | Zimmer Biomet Holdings, Inc. | 17.30B | -0.39% | 1,654,324 | 8.41B |
| 75 | ASND | Ascendis Pharma A/S | 16.58B | -0.35% | 627,616 | 998.25M |
| 76 | MEDP | Medpace Holdings, Inc. | 15.60B | -3.33% | 357,572 | 2.68B |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 15.56B | 1.45% | 1,056,557 | 4.44B |
| 78 | BBIO | BridgeBio Pharma, Inc. | 15.27B | 0.21% | 2,694,510 | 579.96M |
| 79 | DVA | DaVita Inc. | 15.04B | -0.59% | 914,044 | 13.84B |
| 80 | BTSG | BrightSpring Health Services, Inc. | 14.62B | -0.55% | 3,970,831 | 13.65B |
| 81 | EXEL | Exelixis, Inc. | 14.35B | 2.79% | 3,334,610 | 2.38B |
| 82 | IONS | Ionis Pharmaceuticals, Inc. | 14.27B | 3.79% | 2,646,708 | 1.06B |
| 83 | COO | The Cooper Companies, Inc. | 14.02B | -0.99% | 2,195,351 | 4.23B |
| 84 | ALGN | Align Technology, Inc. | 13.27B | -1.68% | 913,540 | 4.10B |
| 85 | SOLV | Solventum Corporation | 13.21B | -2.13% | 1,239,734 | 8.26B |
| 86 | FMS | Fresenius Medical Care AG | 12.98B | 2.50% | 474,496 | 22.32B |
| 87 | ICLR | ICON Public Limited Company | 12.92B | -1.30% | 665,520 | 8.27B |
| 88 | SNN | Smith & Nephew plc | 12.87B | -0.23% | 899,292 | 6.16B |
| 89 | AXSM | Axsome Therapeutics, Inc. | 12.85B | 2.95% | 1,055,992 | 708.24M |
| 90 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.57B | 3.00% | 318,421 | 1.13B |
| 91 | PEN | Penumbra, Inc. | 12.52B | 0.03% | 312,676 | 1.45B |
| 92 | RVTY | Revvity, Inc. | 12.50B | -0.80% | 1,165,428 | 2.90B |
| 93 | ABVX | ABIVAX Société Anonyme | 12.49B | -1.26% | 1,356,110 | 5.67M |
| 94 | SMMT | Summit Therapeutics Inc. | 12.33B | -0.31% | 2,798,470 | - |
| 95 | ELAN | Elanco Animal Health Incorporated | 12.31B | -1.95% | 3,666,629 | 4.89B |
| 96 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.25B | 0.49% | 1,914,966 | 622.01M |
| 97 | MOH | Molina Healthcare, Inc. | 12.13B | 2.28% | 947,620 | 43.10B |
| 98 | RDY | Dr. Reddy's Laboratories Limited | 11.83B | 1.88% | 2,736,505 | 3.58B |
| 99 | BAX | Baxter International Inc. | 11.81B | 1.24% | 5,990,912 | 11.32B |
| 100 | BMRN | BioMarin Pharmaceutical Inc. | 11.66B | 2.65% | 1,598,604 | 3.24B |
| 101 | CYTK | Cytokinetics, Incorporated | 11.62B | -0.01% | 2,293,476 | 105.82M |
| 102 | PODD | Insulet Corporation | 11.19B | 1.11% | 935,126 | 2.90B |
| 103 | CRL | Charles River Laboratories International, Inc. | 11.01B | -1.19% | 806,438 | 4.03B |
| 104 | TECH | Bio-Techne Corporation | 11.00B | -0.44% | 5,483,278 | 1.21B |
| 105 | EHC | Encompass Health Corporation | 10.98B | 3.49% | 1,061,412 | 6.07B |
| 106 | KRYS | Krystal Biotech, Inc. | 10.87B | -1.62% | 274,670 | 417.30M |
| 107 | TEM | Tempus AI, Inc. | 10.79B | -1.00% | 4,100,475 | 1.36B |
| 108 | GMED | Globus Medical, Inc. | 10.70B | -2.07% | 1,514,851 | 3.10B |
| 109 | CORT | Corcept Therapeutics Incorporated | 10.10B | 2.65% | 1,142,047 | 769.10M |
| 110 | APGE | Apogee Therapeutics, Inc. | 10.01B | 0.03% | 1,054,062 | - |
| 111 | ENSG | The Ensign Group, Inc. | 9.90B | 2.42% | 785,892 | 5.27B |
| 112 | HSIC | Henry Schein, Inc. | 9.89B | 0.25% | 1,039,219 | 13.38B |
| 113 | KYMR | Kymera Therapeutics, Inc. | 9.81B | 3.90% | 830,965 | 51.48M |
| 114 | NUVL | Nuvalent, Inc. | 9.79B | 0.04% | 1,083,395 | - |
| 115 | UHS | Universal Health Services, Inc. | 9.76B | 2.03% | 639,257 | 17.76B |
| 116 | HALO | Halozyme Therapeutics, Inc. | 9.68B | 0.98% | 2,037,330 | 1.51B |
| 117 | OSCR | Oscar Health, Inc. | 9.37B | -1.02% | 5,795,606 | 13.30B |
| 118 | ALKS | Alkermes plc | 9.20B | 0.15% | 1,719,311 | 1.56B |
| 119 | IBRX | ImmunityBio, Inc. | 9.17B | -1.68% | 11,232,609 | 140.98M |
| 120 | PTGX | Protagonist Therapeutics, Inc. | 9.06B | 7.11% | 1,374,383 | 74.06M |
| 121 | PRAX | Praxis Precision Medicines, Inc. | 9.03B | 3.33% | 609,134 | 7.46M |
| 122 | BRKR | Bruker Corporation | 8.87B | -5.04% | 2,331,572 | 3.46B |
| 123 | GKOS | Glaukos Corporation | 8.84B | 1.31% | 710,266 | 551.35M |
| 124 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.81B | 98.74% | 80,925,472 | 18.07M |
| 125 | PCVX | Vaxcyte, Inc. | 8.76B | 6.51% | 1,513,686 | - |
| 126 | HIMS | Hims & Hers Health, Inc. | 8.37B | -5.51% | 12,296,620 | 2.37B |
| 127 | IMVT | Immunovant, Inc. | 8.23B | 3.86% | 2,217,190 | - |
| 128 | TGTX | TG Therapeutics, Inc. | 8.23B | 4.67% | 2,105,179 | 700.35M |
| 129 | SYRE | Spyre Therapeutics, Inc. | 8.18B | 6.19% | 1,305,918 | - |
| 130 | ATR | AptarGroup, Inc. | 8.15B | 1.33% | 392,722 | 3.87B |
| 131 | HQY | HealthEquity, Inc. | 8.11B | 0.42% | 664,569 | 1.34B |
| 132 | QGEN | Qiagen N.V. | 8.01B | -0.21% | 3,673,658 | 2.10B |
| 133 | RGEN | Repligen Corporation | 7.89B | -1.15% | 617,789 | 763.34M |
| 134 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.84B | 2.49% | 998,560 | 217.17M |
| 135 | BIO | Bio-Rad Laboratories, Inc. | 7.83B | -0.90% | 294,391 | 2.59B |
| 136 | MIRM | Mirum Pharmaceuticals, Inc. | 7.82B | 5.25% | 902,516 | 569.61M |
| 137 | PTCT | PTC Therapeutics, Inc. | 7.40B | 4.40% | 1,410,794 | 827.11M |
| 138 | LQDA | Liquidia Corporation | 7.22B | 2.55% | 1,219,359 | 288.07M |
| 139 | AVTR | Avantor, Inc. | 6.96B | -1.64% | 6,932,139 | 6.55B |
| 140 | HNGE | Hinge Health, Inc. | 6.91B | 0.88% | 1,994,330 | 646.34M |
| 141 | PACS | PACS Group, Inc. | 6.90B | -3.07% | 904,899 | 5.43B |
| 142 | COGT | Cogent Biosciences, Inc. | 6.84B | 1.45% | 3,723,014 | - |
| 143 | SRRK | Scholar Rock Holding Corporation | 6.78B | 2.17% | 1,144,016 | - |
| 144 | LNTH | Lantheus Holdings, Inc. | 6.73B | 0.57% | 1,154,512 | 1.55B |
| 145 | CHE | Chemed Corporation | 6.42B | 1.01% | 165,071 | 2.54B |
| 146 | LGND | Ligand Pharmaceuticals Incorporated | 6.33B | -0.31% | 316,475 | 274.48M |
| 147 | GRFS | Grifols, S.A. | 6.24B | 0.56% | 976,362 | 8.58B |
| 148 | BLTE | Belite Bio, Inc | 6.20B | 2.38% | 222,580 | - |
| 149 | XENE | Xenon Pharmaceuticals Inc. | 6.13B | 4.67% | 1,442,854 | 7.50M |
| 150 | CGON | CG Oncology, Inc. | 6.10B | -0.09% | 967,931 | 5.07M |
| 151 | BLCO | Bausch + Lomb Corporation | 6.10B | -0.06% | 322,389 | 5.21B |
| 152 | TFX | Teleflex Incorporated | 5.91B | -0.58% | 478,946 | 2.13B |
| 153 | DFTX | Definium Therapeutics, Inc. | 5.90B | 0.34% | 2,588,243 | - |
| 154 | CRSP | CRISPR Therapeutics AG | 5.86B | -1.81% | 1,668,275 | 4.10M |
| 155 | ERAS | Erasca, Inc. | 5.71B | -2.60% | 5,241,622 | - |
| 156 | TWST | Twist Bioscience Corporation | 5.67B | -8.91% | 2,603,990 | 409.48M |
| 157 | CELC | Celcuity Inc. | 5.64B | 6.58% | 1,438,267 | - |
| 158 | AMRX | Amneal Pharmaceuticals, Inc. | 5.44B | 0.77% | 1,815,990 | 3.05B |
| 159 | BLLN | BillionToOne, Inc. | 5.43B | -4.34% | 592,734 | 354.54M |
| 160 | TVTX | Travere Therapeutics, Inc. | 5.38B | 0.64% | 1,273,524 | 536.20M |
| 161 | LEGN | Legend Biotech Corporation | 5.35B | -1.28% | 1,174,075 | 1.14B |
| 162 | STVN | Stevanato Group S.p.A. | 5.35B | 1.61% | 483,669 | 1.39B |
| 163 | RDNT | RadNet, Inc. | 5.33B | -1.58% | 945,781 | 2.14B |
| 164 | DNTH | Dianthus Therapeutics, Inc. | 5.23B | 2.59% | 819,572 | 1.34M |
| 165 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.18B | 7.20% | 947,086 | 754.05M |
| 166 | SHC | Sotera Health Company | 5.14B | 0.90% | 2,973,945 | 1.19B |
| 167 | ORKA | Oruka Therapeutics, Inc. | 5.10B | 1.65% | 2,202,788 | - |
| 168 | INDV | Indivior Pharmaceuticals, Inc. | 4.98B | 2.10% | 1,867,945 | 1.29B |
| 169 | ALHC | Alignment Healthcare, Inc. | 4.97B | -2.08% | 4,204,550 | 4.26B |
| 170 | CAI | Caris Life Sciences, Inc. | 4.94B | -1.91% | 2,677,555 | 907.29M |
| 171 | VKTX | Viking Therapeutics, Inc. | 4.89B | 8.83% | 4,359,822 | - |
| 172 | MANE | Veradermics, Incorporated | 4.88B | -4.32% | 385,413 | - |
| 173 | TXG | 10x Genomics, Inc. | 4.80B | -5.43% | 2,432,457 | 638.78M |
| 174 | EWTX | Edgewise Therapeutics, Inc. | 4.64B | 7.56% | 1,281,118 | - |
| 175 | LIVN | LivaNova PLC | 4.59B | -0.54% | 439,563 | 1.43B |
| 176 | WAY | Waystar Holding Corp. | 4.57B | -0.42% | 2,752,854 | 1.16B |
| 177 | ACAD | ACADIA Pharmaceuticals Inc. | 4.49B | 1.67% | 1,674,460 | 1.10B |
| 178 | VCYT | Veracyte, Inc. | 4.48B | -3.16% | 1,136,485 | 541.74M |
| 179 | NVST | Envista Holdings Corporation | 4.41B | -1.38% | 1,679,982 | 2.81B |
| 180 | TNGX | Tango Therapeutics, Inc. | 4.36B | 0.60% | 2,795,512 | 56.99M |
| 181 | NAMS | NewAmsterdam Pharma Company N.V. | 4.32B | 5.99% | 958,712 | 22.57M |
| 182 | MMED | MiniMed Group, Inc. | 4.32B | 0.52% | 524,507 | 3.10B |
| 183 | MMSI | Merit Medical Systems, Inc. | 4.30B | 0.97% | 666,593 | 1.54B |
| 184 | RLAY | Relay Therapeutics, Inc. | 4.30B | 4.44% | 5,145,109 | 10.68M |
| 185 | LFST | LifeStance Health Group, Inc. | 4.23B | -0.82% | 2,921,928 | 1.49B |
| 186 | DNLI | Denali Therapeutics Inc. | 4.18B | 2.21% | 1,437,184 | - |
| 187 | DOCS | Doximity, Inc. | 4.16B | -0.52% | 3,014,560 | 644.86M |
| 188 | IRTC | iRhythm Holdings, Inc. | 4.11B | -0.75% | 547,714 | 787.85M |
| 189 | CON | Concentra Group Holdings Parent, Inc. | 4.05B | -0.66% | 1,034,914 | 2.23B |
| 190 | GPCR | Structure Therapeutics Inc. | 4.02B | 3.43% | 608,154 | - |
| 191 | DYN | Dyne Therapeutics, Inc. | 3.94B | 4.33% | 3,058,898 | - |
| 192 | TLX | Telix Pharmaceuticals Limited | 3.90B | -3.37% | 174,134 | 803.79M |
| 193 | ICUI | ICU Medical, Inc. | 3.88B | -2.55% | 236,698 | 2.16B |
| 194 | PBLS | Parabilis Medicines, Inc. | 3.86B | 3.94% | 508,644 | - |
| 195 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.85B | -0.03% | 780,071 | 596.96M |
| 196 | IDYA | IDEAYA Biosciences, Inc. | 3.85B | 2.90% | 1,507,036 | 225.27M |
| 197 | RCUS | Arcus Biosciences, Inc. | 3.80B | 0.90% | 794,369 | 236.00M |
| 198 | BEAM | Beam Therapeutics Inc. | 3.77B | 7.36% | 3,941,683 | 164.01M |
| 199 | ALMS | Alumis Inc. | 3.73B | 7.33% | 3,121,145 | 8.40M |
| 200 | BKD | Brookdale Senior Living Inc. | 3.68B | -0.96% | 3,439,480 | 3.00B |
| 201 | ELVN | Enliven Therapeutics, Inc. | 3.56B | 1.82% | 2,012,076 | - |
| 202 | OGN | Organon & Co. | 3.55B | -0.37% | 2,894,912 | 6.16B |
| 203 | RARE | Ultragenyx Pharmaceutical Inc. | 3.52B | 6.44% | 4,421,797 | 670.00M |
| 204 | ARQT | Arcutis Biotherapeutics, Inc. | 3.46B | 6.14% | 2,397,371 | 415.62M |
| 205 | WRBY | Warby Parker Inc. | 3.44B | -4.04% | 2,210,547 | 890.57M |
| 206 | PRVA | Privia Health Group, Inc. | 3.43B | 0.15% | 1,077,940 | 2.25B |
| 207 | HAE | Haemonetics Corporation | 3.40B | -0.19% | 399,425 | 1.33B |
| 208 | OPCH | Option Care Health, Inc. | 3.39B | 0.98% | 1,561,012 | 5.67B |
| 209 | NHC | National HealthCare Corporation | 3.38B | -0.47% | 165,667 | 1.53B |
| 210 | ADPT | Adaptive Biotechnologies Corporation | 3.33B | -3.16% | 2,440,474 | 295.41M |
| 211 | CLDX | Celldex Therapeutics, Inc. | 3.13B | 5.22% | 1,701,313 | 865.00K |
| 212 | ITGR | Integer Holdings Corporation | 3.12B | -1.61% | 534,876 | 1.86B |
| 213 | VERA | Vera Therapeutics, Inc. | 3.08B | 7.05% | 5,127,769 | - |
| 214 | IRON | Disc Medicine, Inc. | 3.05B | 3.57% | 1,243,618 | - |
| 215 | TARS | Tarsus Pharmaceuticals, Inc. | 3.04B | 5.22% | 1,685,125 | 535.08M |
| 216 | GRAL | GRAIL, Inc. | 2.95B | -0.23% | 599,837 | 156.12M |
| 217 | MBX | MBX Biosciences, Inc. | 2.95B | 7.45% | 756,604 | - |
| 218 | RGC | Regencell Bioscience Holdings Limited | 2.95B | 6.06% | 417,079 | - |
| 219 | ACHC | Acadia Healthcare Company, Inc. | 2.94B | 2.67% | 2,793,764 | 3.37B |
| 220 | KLRA | Kailera Therapeutics, Inc. | 2.88B | -4.55% | 1,648,201 | - |
| 221 | QURE | uniQure N.V. | 2.85B | 0.12% | 2,221,345 | 18.09M |
| 222 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.79B | 8.06% | 10,280,196 | 885.72M |
| 223 | SUPN | Supernus Pharmaceuticals, Inc. | 2.78B | 1.48% | 1,017,845 | 776.83M |
| 224 | TRVI | Trevi Therapeutics, Inc. | 2.77B | 8.64% | 5,526,536 | - |
| 225 | IMNM | Immunome, Inc. | 2.76B | 2.05% | 1,561,518 | 4.02M |
| 226 | MLYS | Mineralys Therapeutics, Inc. | 2.69B | 4.60% | 1,234,777 | - |
| 227 | ESTA | Establishment Labs Holdings Inc. | 2.68B | -0.57% | 687,005 | 229.58M |
| 228 | SLS | SELLAS Life Sciences Group, Inc. | 2.65B | -3.16% | 8,164,663 | - |
| 229 | CLOV | Clover Health Investments, Corp. | 2.63B | -1.19% | 5,713,810 | 2.21B |
| 230 | AGIO | Agios Pharmaceuticals, Inc. | 2.62B | 17.71% | 2,776,298 | 66.05M |
| 231 | GRDN | Guardian Pharmacy Services, Inc. | 2.53B | -3.41% | 389,101 | 1.46B |
| 232 | NKTR | Nektar Therapeutics | 2.53B | 2.39% | 1,573,465 | 55.63M |
| 233 | NRIX | Nurix Therapeutics, Inc. | 2.52B | 1.50% | 1,239,831 | 71.78M |
| 234 | TMDX | TransMedics Group, Inc. | 2.46B | -0.16% | 754,297 | 635.89M |
| 235 | XRAY | DENTSPLY SIRONA Inc. | 2.44B | -1.06% | 4,416,878 | 3.68B |
| 236 | NTLA | Intellia Therapeutics, Inc. | 2.44B | -2.30% | 3,171,882 | 66.09M |
| 237 | PHVS | Pharvaris N.V. | 2.42B | 4.12% | 972,781 | - |
| 238 | LMAT | LeMaitre Vascular, Inc. | 2.42B | 1.91% | 383,323 | 256.28M |
| 239 | PGNY | Progyny, Inc. | 2.41B | -0.48% | 1,133,389 | 1.29B |
| 240 | VCEL | Vericel Corporation | 2.40B | 0.84% | 422,920 | 292.09M |
| 241 | KOD | Kodiak Sciences Inc. | 2.39B | 3.46% | 566,228 | - |
| 242 | PBH | Prestige Consumer Healthcare Inc. | 2.39B | 3.19% | 610,003 | 1.09B |
| 243 | AXGN | Axogen, Inc. | 2.37B | -3.05% | 1,291,264 | 238.11M |
| 244 | HTFL | HeartFlow, Inc. | 2.35B | 0.66% | 1,377,640 | 191.42M |
| 245 | ABCL | AbCellera Biologics Inc. | 2.35B | -2.29% | 8,059,925 | 79.21M |
| 246 | BHVN | Biohaven Ltd. | 2.34B | -3.12% | 2,946,765 | - |
| 247 | ASTH | Astrana Health, Inc. | 2.33B | 0.28% | 538,129 | 3.53B |
| 248 | OCUL | Ocular Therapeutix, Inc. | 2.26B | 6.94% | 2,873,910 | 52.04M |
| 249 | VRDN | Viridian Therapeutics, Inc. | 2.26B | 7.79% | 3,477,330 | 70.92M |
| 250 | SGRY | Surgery Partners, Inc. | 2.22B | 1.00% | 1,294,229 | 3.34B |
| 251 | HRMY | Harmony Biosciences Holdings, Inc. | 2.21B | 3.38% | 846,998 | 899.11M |
| 252 | ZLAB | Zai Lab Limited | 2.17B | 1.42% | 606,068 | 453.28M |
| 253 | MD | Pediatrix Medical Group, Inc. | 2.15B | -1.97% | 786,515 | 1.93B |
| 254 | ADMA | ADMA Biologics, Inc. | 2.13B | 0.55% | 2,331,693 | 509.86M |
| 255 | KARD | Kardigan, Inc. | 2.13B | 0.21% | 272,987 | - |
| 256 | AVAH | Aveanna Healthcare Holdings Inc. | 2.09B | 0.73% | 2,575,971 | 2.52B |
| 257 | PVLA | Palvella Therapeutics, Inc. | 2.09B | 3.84% | 152,930 | - |
| 258 | SRPT | Sarepta Therapeutics, Inc. | 2.09B | 3.18% | 2,434,887 | 2.18B |
| 259 | AUPH | Aurinia Pharmaceuticals Inc. | 2.09B | 4.71% | 2,672,095 | 298.30M |
| 260 | GENB | Generate Biomedicines, Inc. | 2.08B | -4.14% | 921,844 | 30.30M |
| 261 | TSHA | Taysha Gene Therapies, Inc. | 2.08B | 1.88% | 3,680,884 | 7.47M |
| 262 | GLUE | Monte Rosa Therapeutics, Inc. | 2.06B | 4.95% | 1,303,446 | 42.95M |
| 263 | SNDX | Syndax Pharmaceuticals, Inc. | 2.06B | 5.25% | 2,294,640 | 217.17M |
| 264 | STOK | Stoke Therapeutics, Inc. | 2.06B | 1.82% | 904,639 | 32.08M |
| 265 | NVCR | NovoCure Limited | 2.05B | 2.31% | 1,057,795 | 674.41M |
| 266 | NEOG | Neogen Corporation | 2.04B | -1.26% | 1,300,949 | 870.56M |
| 267 | UFPT | UFP Technologies, Inc. | 2.04B | -2.93% | 195,304 | 608.85M |
| 268 | RXRX | Recursion Pharmaceuticals, Inc. | 2.04B | -3.03% | 28,855,557 | 66.41M |
| 269 | SION | Sionna Therapeutics, Inc. | 2.03B | 4.20% | 664,396 | - |
| 270 | LKFT | Lakefront Biotherapeutics NV | 2.02B | 0.76% | 156,201 | 1.20B |
| 271 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.02B | 1.11% | 1,517,056 | -665.00K |
| 272 | OMCL | Omnicell, Inc. | 2.02B | -1.95% | 641,579 | 1.23B |
| 273 | BCAX | Bicara Therapeutics Inc. | 2.00B | 4.04% | 1,840,185 | - |
| 274 | ANAB | AnaptysBio, Inc. | 1.99B | 8.05% | 947,776 | 232.39M |
| 275 | BFLY | Butterfly Network, Inc. | 1.98B | -7.90% | 7,658,870 | 102.92M |
| 276 | HCM | HUTCHMED (China) Limited | 1.98B | -4.89% | 56,209 | 548.51M |
| 277 | NUVB | Nuvation Bio Inc. | 1.97B | 1.25% | 7,144,141 | 143.05M |
| 278 | PGEN | Precigen, Inc. | 1.96B | -1.61% | 7,508,521 | 31.60M |
| 279 | ZYME | Zymeworks Inc. | 1.95B | 5.49% | 771,623 | 81.26M |
| 280 | IOVA | Iovance Biotherapeutics, Inc. | 1.94B | 3.82% | 11,634,878 | 285.61M |
| 281 | WGS | GeneDx Holdings Corp. | 1.94B | -5.04% | 656,873 | 442.68M |
| 282 | PLSE | Pulse Biosciences, Inc. | 1.94B | -3.71% | 258,564 | 751.00K |
| 283 | ADUS | Addus HomeCare Corporation | 1.94B | 0.23% | 216,419 | 1.45B |
| 284 | ABSI | Absci Corporation | 1.92B | -1.82% | 4,153,948 | 1.84M |
| 285 | NBTX | Nanobiotix S.A. | 1.92B | -5.60% | 108,271 | 38.27M |
| 286 | ATAI | AtaiBeckley Inc. | 1.91B | 4.64% | 7,712,534 | 3.49M |
| 287 | SNDA | Sonida Senior Living, Inc. | 1.91B | -0.61% | 513,997 | 367.34M |
| 288 | RAPP | Rapport Therapeutics, Inc. | 1.90B | 2.98% | 862,310 | 20.00M |
| 289 | TYRA | Tyra Biosciences, Inc. | 1.90B | 3.50% | 754,577 | - |
| 290 | NEO | NeoGenomics, Inc. | 1.89B | -4.35% | 2,874,738 | 745.97M |
| 291 | DMRA | Damora Therapeutics, Inc. | 1.85B | 0.67% | 588,472 | - |
| 292 | GHRS | GH Research PLC | 1.84B | 2.75% | 155,295 | - |
| 293 | URGN | UroGen Pharma Ltd. | 1.84B | 0.91% | 914,054 | 140.49M |
| 294 | BHC | Bausch Health Companies Inc. | 1.83B | 2.08% | 1,991,299 | 10.53B |
| 295 | ANIP | ANI Pharmaceuticals, Inc. | 1.82B | 1.11% | 211,174 | 923.71M |
| 296 | MAZE | Maze Therapeutics, Inc. | 1.82B | 1.51% | 628,609 | 20.00M |
| 297 | MESO | Mesoblast Limited | 1.82B | -0.28% | 211,475 | 65.38M |
| 298 | AGL | agilon health, inc. | 1.79B | -0.12% | 182,274 | 5.82B |
| 299 | CMPS | COMPASS Pathways plc | 1.75B | 1.17% | 14,233,190 | - |
| 300 | ALMR | Alamar Biosciences, Inc. | 1.75B | -1.68% | 171,950 | 87.16M |
| 301 | ZBIO | Zenas BioPharma, Inc. | 1.75B | 4.65% | 898,542 | 10.00M |
| 302 | VIR | Vir Biotechnology, Inc. | 1.73B | 2.30% | 1,352,430 | 65.50M |
| 303 | HROW | Harrow, Inc. | 1.72B | 2.72% | 802,536 | 268.68M |
| 304 | TDOC | Teladoc Health, Inc. | 1.72B | 2.48% | 4,968,102 | 2.51B |
| 305 | TRLV | Trulieve Cannabis Corp. | 1.72B | 1.25% | 667,490 | 1.17B |
| 306 | IMCR | Immunocore Holdings plc | 1.70B | 4.57% | 1,195,696 | 412.81M |
| 307 | MPLT | MapLight Therapeutics, Inc. | 1.68B | 5.76% | 588,346 | - |
| 308 | HCSG | Healthcare Services Group, Inc. | 1.67B | -0.93% | 556,022 | 1.85B |
| 309 | ATRC | AtriCure, Inc. | 1.66B | 1.27% | 714,721 | 552.16M |
| 310 | FTRE | Fortrea Holdings Inc. | 1.65B | -2.07% | 1,229,230 | 2.71B |
| 311 | AAPG | Ascentage Pharma Group International | 1.65B | -3.56% | 7,835 | 82.08M |
| 312 | INVA | Innoviva, Inc. | 1.64B | 1.97% | 513,405 | 420.69M |
| 313 | KMTS | Kestra Medical Technologies, Ltd. | 1.63B | -0.11% | 404,312 | 83.72M |
| 314 | SEPN | Septerna, Inc. | 1.62B | 7.05% | 843,504 | 72.26M |
| 315 | AVBP | ArriVent BioPharma, Inc. | 1.59B | -0.90% | 402,316 | - |
| 316 | MLTX | MoonLake Immunotherapeutics | 1.58B | 1.43% | 1,386,578 | - |
| 317 | INNV | InnovAge Holding Corp. | 1.58B | -3.80% | 345,928 | 949.17M |
| 318 | SVRA | Savara Inc. | 1.57B | 0.16% | 2,360,657 | - |
| 319 | NVAX | Novavax, Inc. | 1.56B | 1.18% | 4,517,346 | 596.34M |
| 320 | ARDT | Ardent Health, Inc. | 1.55B | - | 402,812 | 6.43B |
| 321 | PRGO | Perrigo Company plc | 1.55B | 0.90% | 3,753,257 | 4.18B |
| 322 | XERS | Xeris Biopharma Holdings, Inc. | 1.54B | 6.81% | 3,494,236 | 314.85M |
| 323 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.53B | 0.34% | 2,625,171 | 204.73M |
| 324 | AKTS | Aktis Oncology, Inc. | 1.52B | 3.84% | 498,427 | 8.28M |
| 325 | INBX | Inhibrx Biosciences, Inc. | 1.48B | 3.72% | 459,448 | 1.30M |
| 326 | COAG | Hemab Therapeutics Holdings, Inc. | 1.47B | 5.07% | 162,037 | - |
| 327 | ENOV | Enovis Corporation | 1.47B | -1.47% | 989,228 | 2.28B |
| 328 | PSNL | Personalis, Inc. | 1.46B | -2.51% | 3,461,580 | 64.52M |
| 329 | CDNA | CareDx, Inc. | 1.46B | -2.58% | 626,128 | 412.82M |
| 330 | INSP | Inspire Medical Systems, Inc. | 1.44B | 1.27% | 1,058,877 | 915.25M |
| 331 | ATEC | Alphatec Holdings, Inc. | 1.44B | 0.54% | 2,777,932 | 787.08M |
| 332 | IMTX | Immatics N.V. | 1.40B | 2.70% | 401,258 | 43.00M |
| 333 | PNTG | The Pennant Group, Inc. | 1.38B | -0.53% | 426,892 | 1.02B |
| 334 | OMDA | Omada Health, Inc. | 1.37B | 0.66% | 2,544,554 | 283.30M |
| 335 | BLFS | BioLife Solutions, Inc. | 1.36B | 0.50% | 711,020 | 101.66M |
| 336 | IART | Integra LifeSciences Holdings Corporation | 1.36B | -3.96% | 1,106,194 | 1.64B |
| 337 | MGTX | MeiraGTx Holdings plc | 1.36B | 5.54% | 2,019,324 | 79.76M |
| 338 | AHCO | AdaptHealth Corp. | 1.35B | -1.17% | 949,637 | 3.29B |
| 339 | PAHC | Phibro Animal Health Corporation | 1.34B | -2.96% | 224,997 | 1.50B |
| 340 | AHG | Akso Health Group | 1.34B | 2.30% | 5,075 | 14.84M |
| 341 | JBIO | Jade Biosciences, Inc. | 1.33B | 5.40% | 1,042,842 | - |
| 342 | ARDX | Ardelyx, Inc. | 1.33B | 0.75% | 4,576,021 | 427.68M |
| 343 | STAA | STAAR Surgical Company | 1.32B | -2.89% | 796,602 | 290.38M |
| 344 | CRVS | Corvus Pharmaceuticals, Inc. | 1.31B | 3.03% | 1,339,830 | - |
| 345 | MNKD | MannKind Corporation | 1.30B | -1.17% | 3,394,139 | 360.78M |
| 346 | NUTX | Nutex Health Inc. | 1.29B | -2.91% | 101,908 | 879.95M |
| 347 | AMN | AMN Healthcare Services, Inc. | 1.29B | -7.05% | 1,006,884 | 3.42B |
| 348 | CAPR | Capricor Therapeutics, Inc. | 1.29B | -0.94% | 1,447,665 | 11.13M |
| 349 | IRMD | IRADIMED CORPORATION | 1.28B | -2.01% | 113,718 | 86.28M |
| 350 | AVLN | Avalyn Pharma Inc. | 1.26B | 2.78% | 406,257 | - |
| 351 | ALVO | Alvotech | 1.25B | 0.87% | 638,833 | 562.04M |
| 352 | SANA | Sana Biotechnology, Inc. | 1.24B | 3.78% | 3,729,000 | - |
| 353 | SDGR | Schrödinger, Inc. | 1.23B | -3.00% | 1,126,234 | 254.91M |
| 354 | WVE | Wave Life Sciences Ltd. | 1.23B | 0.95% | 2,738,323 | 71.80M |
| 355 | PRCT | PROCEPT BioRobotics Corporation | 1.20B | -0.85% | 1,449,218 | 322.02M |
| 356 | AORT | Artivion, Inc. | 1.19B | -0.81% | 572,435 | 458.69M |
| 357 | COLL | Collegium Pharmaceutical, Inc. | 1.18B | -2.75% | 471,253 | 796.33M |
| 358 | LMRI | Lumexa Imaging Holdings, Inc. | 1.18B | -3.23% | 450,913 | 1.03B |
| 359 | EYPT | EyePoint, Inc. | 1.18B | -2.91% | 2,117,887 | 7.61M |
| 360 | AZTA | Azenta, Inc. | 1.17B | -1.17% | 814,410 | 596.48M |
| 361 | AVNS | Avanos Medical, Inc. | 1.17B | - | 790,617 | 715.90M |
| 362 | XNCR | Xencor, Inc. | 1.16B | 5.24% | 719,119 | 97.36M |
| 363 | QDEL | QuidelOrtho Corporation | 1.16B | -5.56% | 1,179,653 | 2.66B |
| 364 | DRTS | Alpha Tau Medical Ltd. | 1.15B | -6.08% | 1,077,271 | - |
| 365 | ORIC | ORIC Pharmaceuticals, Inc. | 1.13B | -0.27% | 2,449,997 | - |
| 366 | OPK | OPKO Health, Inc. | 1.13B | -0.67% | 2,129,122 | 581.12M |
| 367 | CGEM | Cullinan Therapeutics, Inc. | 1.12B | 1.97% | 715,223 | - |
| 368 | CERT | Certara, Inc. | 1.12B | 0.56% | 4,065,088 | 419.75M |
| 369 | OLMA | Olema Pharmaceuticals, Inc. | 1.10B | -1.10% | 1,597,494 | - |
| 370 | SLDB | Solid Biosciences Inc. | 1.10B | 0.72% | 1,416,332 | - |
| 371 | USPH | U.S. Physical Therapy, Inc. | 1.09B | -2.15% | 226,543 | 787.69M |
| 372 | VOR | Vor Biopharma Inc. | 1.09B | - | 1,369,369 | - |
| 373 | BIOA | BioAge Labs, Inc. | 1.08B | -1.77% | 518,344 | 10.32M |
| 374 | KURA | Kura Oncology, Inc. | 1.06B | 8.61% | 3,812,066 | 71.64M |
| 375 | TNDM | Tandem Diabetes Care, Inc. | 1.06B | 0.06% | 1,207,633 | 1.03B |
| 376 | ANNX | Annexon, Inc. | 1.05B | 7.89% | 5,759,445 | - |
| 377 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.05B | 2.16% | 4,745,126 | 69.64M |
| 378 | ETON | Eton Pharmaceuticals, Inc. | 1.03B | -0.74% | 400,047 | 86.93M |
| 379 | CNMD | CONMED Corporation | 1.03B | -2.48% | 433,278 | 1.37B |
| 380 | GDRX | GoodRx Holdings, Inc. | 1.03B | -1.62% | 587,635 | 787.89M |
| 381 | EVO | Evotec SE | 1.02B | -2.40% | 16,895 | 859.03M |
| 382 | ABUS | Arbutus Biopharma Corporation | 1.02B | 4.23% | 5,090,024 | 191.45M |
| 383 | CRON | Cronos Group Inc. | 1.02B | -0.36% | 736,717 | 159.54M |
| 384 | PCRX | Pacira BioSciences, Inc. | 1.02B | 0.90% | 457,757 | 734.86M |
| 385 | AVTX | Avalo Therapeutics, Inc. | 1.01B | -3.56% | 1,443,076 | 59.00K |
| 386 | PHAR | Pharming Group N.V. | 1.01B | 1.05% | 4,634 | 369.49M |
| 387 | JANX | Janux Therapeutics, Inc. | 984.90M | 4.80% | 1,290,151 | 13.73M |
| 388 | LBRX | LB Pharmaceuticals Inc | 983.32M | 2.63% | 412,099 | - |
| 389 | SPTX | Seaport Therapeutics, Inc. | 975.86M | -5.89% | 157,911 | - |
| 390 | DBVT | DBV Technologies S.A. | 971.84M | 11.15% | 366,104 | 5.74M |
| 391 | REPL | Replimune Group, Inc. | 966.21M | 0.35% | 2,097,144 | - |
| 392 | AVR | Anteris Technologies Global Corp. | 965.63M | -6.15% | 1,212,567 | 1.85M |
| 393 | BVS | Bioventus Inc. | 959.81M | -2.46% | 1,109,931 | 576.30M |
| 394 | GERN | Geron Corporation | 955.87M | 3.47% | 11,479,010 | 196.12M |
| 395 | INMD | InMode Ltd. | 921.24M | -0.41% | 409,945 | 374.64M |
| 396 | DSGN | Design Therapeutics, Inc. | 918.74M | -0.94% | 1,136,554 | - |
| 397 | PHAT | Phathom Pharmaceuticals, Inc. | 917.42M | 1.49% | 1,358,957 | 204.89M |
| 398 | ANRO | Alto Neuroscience, Inc. | 901.91M | -1.98% | 662,935 | - |
| 399 | IVA | Inventiva S.A. | 897.76M | 16.92% | 3,292,508 | 7.94M |
| 400 | TENX | Tenax Therapeutics, Inc. | 887.97M | 6.89% | 1,639,906 | - |
| 401 | AMPH | Amphastar Pharmaceuticals, Inc. | 885.39M | 2.40% | 449,984 | 720.53M |
| 402 | TBPH | Theravance Biopharma, Inc. | 881.60M | 0.06% | 981,532 | 109.78M |
| 403 | TALK | Talkspace, Inc. | 872.74M | -0.57% | 2,608,173 | 238.37M |
| 404 | IMMX | Immix Biopharma, Inc. | 855.70M | 15.02% | 4,242,866 | - |
| 405 | ZVRA | Zevra Therapeutics, Inc. | 853.62M | 3.36% | 1,876,005 | 122.29M |
| 406 | CTMX | CytomX Therapeutics, Inc. | 835.98M | 0.79% | 3,194,731 | 35.54M |
| 407 | HSTM | HealthStream, Inc. | 831.17M | -2.13% | 197,082 | 311.78M |
| 408 | OCS | Oculis Holding AG | 818.86M | -1.74% | 505,346 | 1.40M |
| 409 | ESPR | Esperion Therapeutics, Inc. | 814.31M | 0.32% | 7,502,509 | 418.24M |
| 410 | SPRY | ARS Pharmaceuticals, Inc. | 813.29M | -1.68% | 1,235,305 | 98.99M |
| 411 | GMRS | GMR Solutions Inc. | 796.13M | 2.50% | 873,975 | 5.83B |
| 412 | RIGL | Rigel Pharmaceuticals, Inc. | 787.45M | 5.71% | 744,397 | 299.77M |
| 413 | ACRS | Aclaris Therapeutics, Inc. | 784.91M | 2.37% | 1,380,017 | 8.37M |
| 414 | RGNX | REGENXBIO Inc. | 776.50M | 1.28% | 2,757,115 | 87.82M |
| 415 | AURA | Aura Biosciences, Inc. | 775.40M | -0.85% | 814,996 | - |
| 416 | CLYM | Climb Bio, Inc. | 768.44M | 1.13% | 1,452,967 | - |
| 417 | SIBN | SI-BONE, Inc. | 767.24M | -2.15% | 779,686 | 206.22M |
| 418 | ODTX | Odyssey Therapeutics, Inc. | 761.74M | -3.40% | 229,332 | 1.06M |
| 419 | BBNX | Beta Bionics, Inc. | 757.55M | 1.67% | 787,234 | 110.24M |
| 420 | CBLL | CeriBell, Inc. | 753.16M | 0.30% | 466,146 | 95.07M |
| 421 | OMER | Omeros Corporation | 747.64M | -0.10% | 1,236,226 | 9.89M |
| 422 | ALLO | Allogene Therapeutics, Inc. | 742.08M | 2.87% | 14,393,129 | 22.00K |
| 423 | IRWD | Ironwood Pharmaceuticals, Inc. | 735.82M | 2.05% | 3,479,057 | 361.51M |
| 424 | NGNE | Neurogene Inc. | 733.31M | 13.02% | 708,527 | 925.00K |
| 425 | CSTL | Castle Biosciences, Inc. | 722.76M | -1.57% | 234,221 | 339.92M |
| 426 | CADL | Candel Therapeutics, Inc. | 721.71M | -1.79% | 1,575,901 | - |
| 427 | SLBT | SL Science Holding Limited | 720.85M | -5.41% | 94,230 | - |
| 428 | PRME | Prime Medicine, Inc. | 720.66M | - | 4,131,846 | 4.03M |
| 429 | SSII | SS Innovations International, Inc. | 716.47M | -4.02% | 31,698 | 48.47M |
| 430 | TCMD | Tactile Systems Technology, Inc. | 710.30M | -1.19% | 260,378 | 343.52M |
| 431 | CRMD | CorMedix Inc. | 695.87M | 0.91% | 841,645 | 400.05M |
| 432 | TRAX | First Tracks Biotherapeutics, Inc. | 690.17M | -1.30% | 566,853 | - |
| 433 | TECX | Tectonic Therapeutic, Inc. | 689.39M | 3.73% | 365,309 | - |
| 434 | PHR | Phreesia, Inc. | 676.84M | -1.35% | 765,895 | 495.59M |
| 435 | FTH | Faeth Therapeutics, Inc. | 673.08M | 6.61% | 166,640 | - |
| 436 | RLMD | Relmada Therapeutics, Inc. | 672.35M | 1.26% | 1,869,428 | - |
| 437 | FDMT | 4D Molecular Therapeutics, Inc. | 670.18M | 0.79% | 650,957 | 88.24M |
| 438 | ACHV | Achieve Life Sciences, Inc. | 669.34M | 1.09% | 1,732,178 | - |
| 439 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 664.09M | -1.43% | 369,377 | - |
| 440 | AGMB | AgomAb Therapeutics NV | 654.01M | -1.78% | 97,754 | - |
| 441 | SGP | SpyGlass Pharma, Inc. | 652.62M | 2.25% | 106,210 | - |
| 442 | CERS | Cerus Corporation | 645.19M | -1.83% | 3,083,795 | 216.56M |
| 443 | GYRE | Gyre Therapeutics, Inc. | 640.52M | -3.44% | 106,079 | 117.05M |
| 444 | DRUG | Bright Minds Biosciences Inc. | 639.81M | -3.02% | 254,213 | - |
| 445 | MNPR | Monopar Therapeutics Inc. | 637.86M | -1.96% | 163,567 | - |
| 446 | EIKN | Eikon Therapeutics, Inc. | 628.01M | -3.57% | 443,141 | - |
| 447 | MDXG | MiMedx Group, Inc. | 625.57M | 3.19% | 1,478,181 | 389.42M |
| 448 | BWAY | BrainsWay Ltd. | 622.03M | -6.49% | 72,630 | 56.22M |
| 449 | EVH | Evolent Health, Inc. | 616.40M | -4.53% | 2,055,162 | 1.89B |
| 450 | DNA | Ginkgo Bioworks Holdings, Inc. | 610.13M | -7.62% | 1,162,218 | 151.40M |
| 451 | NPCE | NeuroPace, Inc. | 606.87M | 2.71% | 234,484 | 99.53M |
| 452 | NVCT | Nuvectis Pharma, Inc. | 605.29M | -2.19% | 425,430 | - |
| 453 | FLGT | Fulgent Genetics, Inc. | 596.98M | -1.73% | 262,263 | 320.35M |
| 454 | PROK | ProKidney Corp. | 589.02M | -2.01% | 1,039,130 | 889.00K |
| 455 | CTKB | Cytek Biosciences, Inc. | 588.89M | -1.30% | 878,021 | 204.17M |
| 456 | KYTX | Kyverna Therapeutics, Inc. | 588.50M | 5.68% | 1,200,914 | - |
| 457 | ALT | Altimmune, Inc. | 587.31M | -1.95% | 4,619,754 | 36.00K |
| 458 | TOI | The Oncology Institute, Inc. | 579.90M | 6.62% | 2,213,120 | 545.76M |
| 459 | EDIT | Editas Medicine, Inc. | 575.48M | 2.74% | 2,819,429 | 38.69M |
| 460 | ASMB | Assembly Biosciences, Inc. | 574.01M | 0.22% | 177,789 | 71.10M |
| 461 | CBIO | Crescent Biopharma, Inc. | 565.89M | 0.41% | 222,818 | 11.88M |
| 462 | STTK | Shattuck Labs, Inc. | 556.70M | 0.28% | 1,428,436 | 1.00M |
| 463 | ARVN | Arvinas, Inc. | 554.24M | 1.66% | 844,417 | 89.40M |
| 464 | MYGN | Myriad Genetics, Inc. | 553.47M | -2.82% | 1,135,799 | 829.00M |
| 465 | XOMA | XOMA Royalty Corporation | 550.43M | 0.09% | 144,744 | 48.56M |
| 466 | ANGO | AngioDynamics, Inc. | 544.79M | 0.69% | 493,843 | 313.73M |
| 467 | CTNM | Contineum Therapeutics, Inc. | 544.35M | -6.25% | 491,421 | - |
| 468 | FBRX | Forte Biosciences, Inc. | 543.69M | 9.02% | 500,708 | - |
| 469 | AQST | Aquestive Therapeutics, Inc. | 543.20M | 2.12% | 1,353,872 | 50.27M |
| 470 | WEAV | Weave Communications, Inc. | 541.84M | 1.64% | 1,250,788 | 248.72M |
| 471 | CTEV | Claritev Corporation | 539.05M | -4.64% | 69,014 | 978.76M |
| 472 | STRO | Sutro Biopharma, Inc. | 532.41M | 4.90% | 583,318 | 99.61M |
| 473 | CLPT | ClearPoint Neuro, Inc. | 524.22M | -2.89% | 425,282 | 40.61M |
| 474 | RZLT | Rezolute, Inc. | 519.20M | 0.81% | 1,545,384 | - |
| 475 | CYH | Community Health Systems, Inc. | 517.43M | 3.80% | 1,928,786 | 12.29B |
| 476 | OVID | Ovid Therapeutics Inc. | 515.13M | 5.75% | 3,312,955 | 7.12M |
| 477 | TLRY | Tilray Brands, Inc. | 514.11M | -1.60% | 3,432,896 | 858.28M |
| 478 | NNNN | Anbio Biotechnology | 513.53M | -2.82% | 35,259 | 8.65M |
| 479 | NRC | NRC Health | 513.16M | 1.20% | 113,323 | 138.64M |
| 480 | KIDS | OrthoPediatrics Corp. | 509.08M | -3.08% | 190,619 | 243.30M |
| 481 | OCGN | Ocugen, Inc. | 507.78M | 0.67% | 4,758,937 | 4.47M |
| 482 | PRTA | Prothena Corporation plc | 506.78M | 1.89% | 520,543 | 57.94M |
| 483 | CABA | Cabaletta Bio, Inc. | 505.47M | 2.99% | 7,490,146 | - |
| 484 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 5.42M |
| 485 | VALN | Valneva SE | 495.19M | -2.59% | 26,643 | 180.25M |
| 486 | PRLD | Prelude Therapeutics Incorporated | 492.91M | -0.40% | 320,074 | 16.72M |
| 487 | PACB | Pacific Biosciences of California, Inc. | 484.54M | -6.02% | 3,669,267 | 160.03M |
| 488 | ZURA | Zura Bio Limited | 482.59M | -5.22% | 1,261,498 | - |
| 489 | CCCC | C4 Therapeutics, Inc. | 480.97M | 5.07% | 4,373,751 | 34.86M |
| 490 | EVMN | Evommune, Inc. | 480.49M | 7.93% | 1,925,441 | 10.00M |
| 491 | SLN | Silence Therapeutics plc | 479.42M | -4.06% | 617,739 | 839.00K |
| 492 | SGMT | Sagimet Biosciences Inc. | 474.87M | -0.65% | 1,341,023 | - |
| 493 | OFIX | Orthofix Medical Inc. | 473.74M | 1.30% | 527,086 | 825.37M |
| 494 | DCTH | Delcath Systems, Inc. | 463.97M | -0.30% | 395,726 | 90.44M |
| 495 | VMD | Viemed Healthcare, Inc. | 462.73M | -0.49% | 287,411 | 286.57M |
| 496 | BNTC | Benitec Biopharma Inc. | 461.72M | 1.82% | 110,416 | - |
| 497 | ARTV | Artiva Biotherapeutics, Inc. | 460.62M | 0.42% | 316,853 | 251.00K |
| 498 | EOLS | Evolus, Inc. | 457.03M | -0.72% | 705,990 | 301.79M |
| 499 | VCRE | Vicore Pharma Holding AB (publ) | 456.47M | - | 617,354 | 370.61K |
| 500 | SOPH | SOPHiA GENETICS SA | 456.39M | 1.87% | 284,754 | 81.18M |